US$ 27.62
glp 1 receptor agonists GLP-1 GLP-1 receptor agonists and next-generation
Description
Nancy G

There is not an Ozempic Class Action Lawsuit

doi: 10.1016/j.bbr.2018.08.006 Summary Keywords Alzheimers disease, GLP-1R agonists, cognitive function, amyloid beta, tau phosphorylation Citation Du H, Meng X, Yao Y and Xu J (2022) The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimers disease

This research led to the development of two blockbuster weight-loss drugs: Wegovy by Novo Nordisk and Zepbound by Eli Lilly, now prescribed to millions as obesity affects 1 in 8 people globally

Despite a significant number of bills in 2023 and 2024 that would have required mandated coverage of GLP-1s in Medicaid, state employee health plans, or for health insurers regulated by the state, only Arkansas, California, Maryland, New Mexico, Pennsylvania, and Texas have introduced legislation mandating coverage in 2025 to date

The baseline HbA1c in the tirzepatide arms was 7.85%7.97% and 8.05% in the study arm receiving a placebo
